Track the Vivesto AB stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Market capitalisation: €93.6m. The latest transaction was disclosed on 7 July 2026 (Purchase). Among the most active insiders: Peter Zonabend. All data is accessible without an account.
Analysts rate Vivesto AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 24.00.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Vivesto AB is a company listed on the XSTO market. It specializes in the development of innovative treatments for serious diseases.